Common Stock Equivalents (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of common stock equivalents |
The Company had the following common stock equivalents at March 31, 2019 and 2018. These are excluded from the loss per share calculation as they are considered anti-dilutive.
|
|||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- Definition Tabular disclosure of common stock equivalents. No definition available.
|
| X | ||||||||||
- References No definition available.
|